To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Description of the SAGhE … - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.

Journal article
Authors Anthony J Swerdlow
Rosie Cooke
Kerstin Albertsson-Wikland
Birgit Borgström
Gary Butler
Stefano Cianfarani
Peter Clayton
Joël Coste
Annalisa Deodati
Emmanuel Ecosse
Ruth Gausche
Claudio Giacomozzi
Wieland Kiess
Anita C S Hokken-Koelega
Claudia E Kuehni
Fabienne Landier
Marc Maes
Primus-E Mullis
Roland Pfaffle
Lars Sävendahl
Grit Sommer
Muriel Thomas
Sally Tollerfield
Gladys R J Zandwijken
Jean-Claude Carel
Published in Hormone research in paediatrics
Volume 84
Issue 3
Pages 172-183
ISSN 1663-2826
Publication year 2015
Published at Institute of Neuroscience and Physiology, Department of Physiology
Pages 172-183
Language en
Links dx.doi.org/10.1159/000435856
Subject categories Pediatrics

Abstract

The long-term safety of growth hormone treatment is uncertain. Raised risks of death and certain cancers have been reported inconsistently, based on limited data or short-term follow-up by pharmaceutical companies.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?